2 dividend growth shares I’ve just bought for my Stocks and Shares ISA

Stephen Wright’s been looking beyond the UK for dividend shares in the last couple of weeks. Here are the opportunities he thinks are too good to miss.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With the new financial year under way, I’ve been looking for stocks to buy. And I’ve got things moving with a pair of dividend shares look like a bargain to me.

Neither is a UK stock, which is unusual for me. But a delay to interest rate cuts across the Atlantic has created some opportunities in companies that look set to increase their dividends over time.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

US stocks

US stocks have been falling lately following some worrying macroeconomic news. Specifically, the latest data indicates that the rate of inflation has crept back up to 3.5% from 3.2%.

By itself, I don’t think this is a huge issue – I’d expect businesses to be able to cope with 3.5% inflation. The issue though, is that it means interest rates are likely to stay higher for longer.

The US central bank has said it plans to start bringing down rates when inflation reaches 2%. And there had been some optimism this might be happening in the next couple of months.

To some extent, the level of the S&P 500 was already reflecting this. So news of rising inflation – which makes imminent rate cuts less likely – has been causing US share prices to fall.

Pfizer

Shares in Pfizer (NYSE:PFE) are down 37% from their 52-week high as Covid-19-related product demand faltered. I think the outlook for the business is much better than the market is giving it credit for though.

A return to the $6.58 in earnings per share the company reported in 2022 looks unlikely, but a $26 share price clearly reflects this. Analysts are forecasting $2.22 for this year, rising to $3.01 in 2026.

There’s no question the stock’s a risky investment – drug development is expensive and returns are uncertain. And attempting to grow through acquisition comes with a danger of overpaying.

but at $26, I think the stock’s become too cheap to ignore. If the company manages to keep increasing its dividend, I’ll get a very good return over time by buying at today’s prices.

Realty Income

Realty Income (NYSE:O) is a real estate investment trust (REIT) with an enviable track record of dividend growth. But the stock’s 20% off its highs, due to one of its largest tenants closing stores.

By itself, I don’t think this is a big problem – Realty Income’s diversified portfolio means the effect is likely to be somewhat limited. The issue comes with the possibility of more widespread closures.

That’s a genuine concern. But with no company making up more than 3.8% of Realty Income’s total rent and the average tenancy having 10 years until expiry, I don’t see any imminent danger here.

As a result, I’ve been buying the stock for my Stocks and Shares ISA. Future growth might be slow and steady, but this is a chance to buy the stock at an unusually low price, so I’m looking to take advantage.

Dividend taxes

For UK investors, there’s an obvious disadvantage to investing in US dividend shares. Distributions are taxed at 30% (reduced to 15% with a W-8BEN form), rather than zero in a Stocks and Shares ISA.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice.

That’s not something to ignore. But even with this in mind, I think the opportunities in Pfizer and Realty Income are just too cheap to miss at the moment.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Stephen Wright has positions in Pfizer and Realty Income. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

2 ISA mistakes I’m keen to avoid

Looking to make the most of your ISA? Here are two errors Royston Wild thinks all savers and investors need…

Read more »

Investing Articles

Want a £1,320 passive income in 2025? These 2 UK shares could deliver it!

These dividend stocks have long histories of paying large and growing dividends. They're tipped to deliver more huge rewards in…

Read more »

Investing Articles

With P/E ratios below 8, I think these FTSE 250 shares are bargains!

The forward P/E ratios on these FTSE 250 shares are far below the index average of 14.1 times. I think…

Read more »

Investing Articles

Are stocks and shares the only way to become an ISA millionaire?

With Cash ISAs offering 5%, do stocks and shares make sense at the moment? Over the longer term, Stephen Wright…

Read more »

Dividend Shares

4,775 shares in this dividend stock could yield me £1.6k a year in passive income

Jon Smith explains how he can build passive income from dividend payers via regular investing that can compound quickly.

Read more »

Investing Articles

Is the Rolls-Royce share price heading to 655p? This analyst thinks so

While the Rolls-Royce share price continues to thrash the FTSE 100, this writer has a couple of things on his…

Read more »

Investing Articles

What’s going on with the National Grid share price now?

Volatility continues for the National Grid share price. Is this a warning sign for investors to heed or a buying…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
US Stock

This is a huge week for Nvidia stock

It’s a make-or-break week for Nvidia stock as the company is posting its Q3 earnings on Wednesday. Here’s what investors…

Read more »